Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SynFine Research is a specialized contract research organization (CRO) that provides custom organic synthesis services to the global pharmaceutical, biotechnology, and agrochemical industries. Founded in 2002 and based in Richmond Hill, Canada, the company excels in the synthesis of complex molecules, including stable isotope-labeled compounds, drug metabolites, and process impurities. These high-purity reference standards are essential for drug metabolism and pharmacokinetics (DMPK) studies, as well as regulatory compliance. In 2014, SynFine Research was acquired by Toronto Research Chemicals (TRC), which subsequently became part of the LGC Group. Today, SynFine's expertise is integrated into TRC's extensive catalog of over 350,000 products, supporting researchers in drug discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SynFine Research.